Brief: Enorama Pharma Q3 Operating Loss Widens To SEK 7.5 Mln
13/11/2019 08:23
Nov 13 (Reuters) - Enorama Pharma AB ERMA.ST :
* Q3 OPERATING LOSS SEK 7.5 MILLION VERSUS LOSS SEK 3.3
MILLION
YEAR AGO
* Q3 NET SALES SEK 2.3 MILLION VERSUS SEK 833,000 YEAR AGO
Source text for Eikon: ID:nWkr5mYbCr
Further company coverage: ERMA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO